{{Rsnum
|rsid=4901706
|Gene=TMEM260
|Chromosome=14
|position=56647667
|Orientation=plus
|GMAF=0.1667
|Gene_s=TMEM260
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 5.5 | 94.5
| HCB | 11.2 | 48.5 | 40.3
| JPT | 3.7 | 39.4 | 56.9
| YRI | 3.4 | 39.3 | 57.2
| ASW | 5.4 | 23.2 | 71.4
| CHB | 11.2 | 48.5 | 40.3
| CHD | 15.7 | 38.0 | 46.3
| GIH | 0.0 | 14.9 | 85.1
| LWK | 4.5 | 39.1 | 56.4
| MEX | 6.9 | 39.7 | 53.4
| MKK | 9.6 | 33.3 | 57.1
| TSI | 1.0 | 12.0 | 87.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24530479
|Title=A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma
}}

{{PMID Auto
|PMID=17584784
|Title=Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
|OA=1
}}

{{PMID Auto
|PMID=24831772
|Title=A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}